Published in Rev Diabet Stud on November 10, 2005
Treatment with CD20-specific antibody prevents and reverses autoimmune diabetes in mice. J Clin Invest (2007) 2.81
Differences in baseline lymphocyte counts and autoreactivity are associated with differences in outcome of islet cell transplantation in type 1 diabetic patients. Diabetes (2009) 1.27
Transient B-cell depletion with anti-CD20 in combination with proinsulin DNA vaccine or oral insulin: immunologic effects and efficacy in NOD mice. PLoS One (2013) 0.97
B Cell in Autoimmune Diseases. Scientifica (Cairo) (2012) 0.90
Modulation of diabetes in NOD mice by GAD65-specific monoclonal antibodies is epitope specific and accompanied by anti-idiotypic antibodies. Immunology (2007) 0.81
Pathogenic mechanisms in type 1 diabetes: the islet is both target and driver of disease. Rev Diabet Stud (2012) 0.80
Translational Mini-Review Series on B Cell-Directed Therapies: B cell-directed therapy for autoimmune diseases. Clin Exp Immunol (2009) 0.80
Zinc transporter 8 (ZnT8) autoantibody epitope specificity and affinity examined with recombinant ZnT8 variant proteins in specific ZnT8R and ZnT8W autoantibody-positive type 1 diabetes patients. Clin Exp Immunol (2015) 0.76
B cell depletion in autoimmune diabetes: insights from murine models. Expert Opin Ther Targets (2011) 0.75
Type 1 diabetes research: Newer approaches and exciting developments. Int J Diabetes Dev Ctries (2009) 0.75
Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis. N Engl J Med (2004) 14.53
Altered immunoglobulin expression and functional silencing of self-reactive B lymphocytes in transgenic mice. Nature (1988) 9.17
Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature (1990) 6.71
Type 1 diabetes: new perspectives on disease pathogenesis and treatment. Lancet (2001) 6.14
Receptor editing in self-reactive bone marrow B cells. J Exp Med (1993) 5.49
Clonal deletion of B lymphocytes in a transgenic mouse bearing anti-MHC class I antibody genes. Nature (1989) 5.48
Insulin antibodies in insulin-dependent diabetics before insulin treatment. Science (1983) 4.16
Elimination from peripheral lymphoid tissues of self-reactive B lymphocytes recognizing membrane-bound antigens. Nature (1991) 4.04
Early expression of antiinsulin autoantibodies of humans and the NOD mouse: evidence for early determination of subsequent diabetes. Proc Natl Acad Sci U S A (2000) 3.89
Development of type 1 diabetes despite severe hereditary B-lymphocyte deficiency. N Engl J Med (2001) 3.85
Targeted disruption of mu chain membrane exon causes loss of heavy-chain allelic exclusion. Nature (1992) 3.82
The innate mononuclear phagocyte network depletes B lymphocytes through Fc receptor-dependent mechanisms during anti-CD20 antibody immunotherapy. J Exp Med (2004) 3.56
Activation of natural killer T cells by alpha-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes. Nat Med (2001) 3.56
The natural killer T-cell ligand alpha-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice. Nat Med (2001) 3.39
B lymphocytes are essential for the initiation of T cell-mediated autoimmune diabetes: analysis of a new "speed congenic" stock of NOD.Ig mu null mice. J Exp Med (1996) 3.35
Natural autoantibodies. Curr Opin Immunol (1995) 3.00
The histopathology of the pancreas in type 1 (insulin-dependent) diabetes mellitus: a 25-year review of deaths in patients under 20 years of age in the United Kingdom. Diabetologia (1986) 2.73
Mononuclear cell infiltration and its relation to the expression of major histocompatibility complex antigens and adhesion molecules in pancreas biopsy specimens from newly diagnosed insulin-dependent diabetes mellitus patients. J Clin Invest (1993) 2.64
B lymphocytes are critical antigen-presenting cells for the initiation of T cell-mediated autoimmune diabetes in nonobese diabetic mice. J Immunol (1998) 2.63
Induction of autoreactive B cells allows priming of autoreactive T cells. J Exp Med (1991) 2.60
A defect in central tolerance in NOD mice. Nat Immunol (2001) 2.59
Autoantibodies in newly diagnosed diabetic children immunoprecipitate human pancreatic islet cell proteins. Nature (1982) 2.58
Autoimmune islet destruction in spontaneous type 1 diabetes is not beta-cell exclusive. Nat Med (2003) 2.40
Combined use of autoantibodies (IA-2 autoantibody, GAD autoantibody, insulin autoantibody, cytoplasmic islet cell antibodies) in type 1 diabetes: Combinatorial Islet Autoantibody Workshop. Diabetes (1998) 2.38
Peripheral deletion of self-reactive B cells. Nature (1991) 2.34
B lymphocytes induce the formation of follicular dendritic cell clusters in a lymphotoxin alpha-dependent fashion. J Exp Med (1998) 2.32
Do B cells drive the diversification of immune responses? Immunol Today (1993) 2.31
Elimination of maternally transmitted autoantibodies prevents diabetes in nonobese diabetic mice. Nat Med (2002) 2.29
B lymphocytes can be competent antigen-presenting cells for priming CD4+ T cells to protein antigens in vivo. J Immunol (1995) 2.29
Immunoglobulin signal transduction guides the specificity of B cell-T cell interactions and is blocked in tolerant self-reactive B cells. J Exp Med (1994) 2.23
Modulation of antigen processing by bound antibodies can boost or suppress class II major histocompatibility complex presentation of different T cell determinants. J Exp Med (1995) 2.05
Lipopolysaccharide-activated B cells down-regulate Th1 immunity and prevent autoimmune diabetes in nonobese diabetic mice. J Immunol (2001) 1.89
Breaking T cell tolerance with foreign and self co-immunogens. A study of autoimmune B and T cell epitopes of cytochrome c. J Immunol (1992) 1.89
Breakdown of self-tolerance in anergic B lymphocytes. Nature (1991) 1.87
The mechanisms of action of rituximab in the elimination of tumor cells. Semin Oncol (2003) 1.82
B lymphocytes are crucial antigen-presenting cells in the pathogenic autoimmune response to GAD65 antigen in nonobese diabetic mice. J Immunol (1998) 1.81
Islet cell antigen 512 is a diabetes-specific islet autoantigen related to protein tyrosine phosphatases. J Immunol (1994) 1.77
Investigation of the role of B-cells in type 1 diabetes in the NOD mouse. Diabetes (2004) 1.76
B-cells are required for the initiation of insulitis and sialitis in nonobese diabetic mice. Diabetes (1997) 1.75
Defective central tolerance induction in NOD mice: genomics and genetics. Immunity (2005) 1.74
Distinct roles of dendritic cells and B cells in Va14Ja18 natural T cell activation in vivo. J Immunol (2005) 1.67
Relationship of the 37,000- and 40,000-M(r) tryptic fragments of islet antigens in insulin-dependent diabetes to the protein tyrosine phosphatase-like molecule IA-2 (ICA512). J Clin Invest (1995) 1.60
ICA 512, an autoantigen of type I diabetes, is an intrinsic membrane protein of neurosecretory granules. EMBO J (1996) 1.59
I-Ag7-mediated antigen presentation by B lymphocytes is critical in overcoming a checkpoint in T cell tolerance to islet beta cells of nonobese diabetic mice. J Immunol (1999) 1.56
Identification of protein tyrosine phosphatase-like IA2 (islet cell antigen 512) as the insulin-dependent diabetes-related 37/40K autoantigen and a target of islet-cell antibodies. J Immunol (1995) 1.53
The preferential ability of B lymphocytes to act as diabetogenic APC in NOD mice depends on expression of self-antigen-specific immunoglobulin receptors. Eur J Immunol (2002) 1.50
B cell specificity contributes to the outcome of diabetes in nonobese diabetic mice. J Immunol (2001) 1.45
Insulitis in type 1 (insulin-dependent) diabetes mellitus in man--macrophages, lymphocytes, and interferon-gamma containing cells. J Pathol (1991) 1.34
Macrophage infiltration precedes and is a prerequisite for lymphocytic insulitis in pancreatic islets of pre-diabetic BB rats. Diabetologia (1989) 1.32
Effective B cell depletion with rituximab in the treatment of autoimmune diseases. Immunobiology (2002) 1.29
Direct evidence for the contribution of B cells to the progression of insulitis and the development of diabetes in non-obese diabetic mice. Int Immunol (1997) 1.29
Islet cell autoantigens in insulin-dependent diabetes. J Clin Invest (1993) 1.28
Use of rituximab, the new FDA-approved antibody. Curr Opin Oncol (1998) 1.21
Expression of the co-stimulator molecule B7-1 in pancreatic beta-cells accelerates diabetes in the NOD mouse. Diabetes (1995) 1.21
Uncoupling of anergy from developmental arrest in anti-insulin B cells supports the development of autoimmune diabetes. J Immunol (2005) 1.20
Antibodies to islet 37k antigen, but not to glutamate decarboxylase, discriminate rapid progression to IDDM in endocrine autoimmunity. Diabetes (1994) 1.19
Anergy and not clonal ignorance determines the fate of B cells that recognize a physiological autoantigen. J Immunol (2001) 1.16
Anti-CD20 monoclonal antibody (Rituximab) for life-threatening autoimmune haemolytic anaemia in a patient with systemic lupus erythematosus. Br J Haematol (2002) 1.15
Progression to diabetes in relatives with islet autoantibodies. Is it inevitable? Diabetes Care (1999) 1.13
Defective CD8+ T cell peripheral tolerance in nonobese diabetic mice. J Immunol (2001) 1.12
Analysis of the role of variation of major histocompatibility complex class II expression on nonobese diabetic (NOD) peripheral T cell response. J Exp Med (1998) 1.11
High incidence of thyroiditis and anti-thyroid autoantibodies in NOD mice. Diabetes (1992) 1.10
GAD65-specific autoantibodies enhance the presentation of an immunodominant T-cell epitope from GAD65. Diabetes (2000) 1.10
Natural killer T cells: natural or unnatural regulators of autoimmunity? Curr Opin Immunol (2003) 1.09
Suppressive effect of glutamic acid decarboxylase 65-specific autoimmune B lymphocytes on processing of T cell determinants located within the antibody epitope. J Immunol (2002) 1.08
Peritoneal B cells govern the outcome of diabetes in non-obese diabetic mice. Eur J Immunol (2004) 1.05
B cell selection defects underlie the development of diabetogenic APCs in nonobese diabetic mice. J Immunol (2004) 1.05
Characterization of anergic anti-DNA B cells: B cell anergy is a T cell-independent and potentially reversible process. Int Immunol (1999) 1.03
Impaired CD4 T cell activation due to reliance upon B cell-mediated costimulation in nonobese diabetic (NOD) mice. J Immunol (2000) 1.03
Development and function of diabetogenic T-cells in B-cell-deficient nonobese diabetic mice. Diabetes (2001) 1.02
Immunoglobulin-mediated prevention of autoimmune diabetes in the non-obese diabetic (NOD) mouse. Scand J Immunol (1991) 1.01
Development of insulitis and diabetes in B cell-deficient NOD mice. J Autoimmun (1997) 1.01
Impaired activation of islet-reactive CD4 T cells in pancreatic lymph nodes of B cell-deficient nonobese diabetic mice. J Immunol (2001) 1.00
Modulation of antigen presentation by autoreactive B cell clones specific for GAD65 from a type I diabetic patient. Clin Exp Immunol (2004) 0.99
Hemolytic anemia in non-obese diabetic mice. Eur J Immunol (1991) 0.98
The role of lymphocyte subsets in accelerated diabetes in nonobese diabetic-rat insulin promoter-B7-1 (NOD-RIP-B7-1) mice. J Exp Med (1998) 0.96
Multiple germline kappa light chains generate anti-insulin B cells in nonobese diabetic mice. J Immunol (2005) 0.95
The natural autoantibody repertoire of nonobese diabetic mice is highly active. J Immunol (2002) 0.95
Islet-infiltrating B-cells in nonobese diabetic mice predominantly target nervous system elements. Diabetes (2005) 0.90
Processing of immunoglobulin-associated antigen in B lymphocytes. Cold Spring Harb Symp Quant Biol (1989) 0.90
Maternal factors in a model of type 1 diabetes differentially affect the development of insulitis and overt diabetes in offspring. Diabetes (2005) 0.90
B lymphocyte depletion in rheumatoid arthritis: targeting of CD20. Curr Dir Autoimmun (2005) 0.89
Effect of anti-CD20 (rituximab) on resistant thrombocytopenia in autoimmune lymphoproliferative syndrome. Br J Haematol (2002) 0.88
Somatically mutated B cell pool provides precursors for insulin antibodies. J Immunol (1996) 0.83
Dysregulated B7-1 and B7-2 expression on nonobese diabetic mouse B cells is associated with increased T cell costimulation and the development of insulitis. J Immunol (2005) 0.83
Developments in the prediction of type 1 diabetes mellitus, with special reference to insulin autoantibodies. Diabetes Metab Res Rev (2005) 0.81
Analysis of VH gene utilisation in the non-obese diabetic mouse. Autoimmunity (1993) 0.79
B lymphocytes not required for progression from insulitis to diabetes in non-obese diabetic mice. Immunol Cell Biol (2001) 0.78
Genetic control of T and B lymphocyte activation in nonobese diabetic mice. J Immunol (2001) 0.77
Neonatal treatment with monoclonal natural antibodies restores a normal pattern of VH gene utilization in the non-obese diabetic mouse. Int Immunol (1994) 0.77
Successful treatment of a patient with hairy cell leukemia and pentostatin-induced autoimmune thrombocytopenia with rituximab. Am J Hematol (2003) 0.76
Treatment with CD20-specific antibody prevents and reverses autoimmune diabetes in mice. J Clin Invest (2007) 2.81
The phosphodiesterase-5 inhibitor vardenafil reduces oxidative stress while reversing pulmonary arterial hypertension. Cardiovasc Res (2013) 2.08
MRI findings of primary CNS lymphoma in 26 immunocompetent patients. Korean J Radiol (2010) 1.79
Investigation of the role of B-cells in type 1 diabetes in the NOD mouse. Diabetes (2004) 1.76
Absence of transfusion-associated microchimerism in pediatric and adult recipients of leukoreduced and gamma-irradiated blood components. Transfusion (2011) 1.59
Enhanced ascertainment of microchimerism with real-time quantitative polymerase chain reaction amplification of insertion-deletion polymorphisms. Transfusion (2006) 1.50
The role of transplacental microtransfusions of maternal lymphocytes in HIV transmission to newborns. AIDS (2008) 1.42
Induction and acceleration of insulitis/diabetes in mice with a viral mimic (polyinosinic-polycytidylic acid) and an insulin self-peptide. Proc Natl Acad Sci U S A (2002) 1.40
Analysis of structure and function relationships of an autoantigenic peptide of insulin bound to H-2K(d) that stimulates CD8 T cells in insulin-dependent diabetes mellitus. Proc Natl Acad Sci U S A (2002) 1.31
West Nile virus nucleic acid persistence in whole blood months after clearance in plasma: implication for transfusion and transplantation safety. Transfusion (2014) 1.30
miR-338-3p suppresses invasion of liver cancer cell by targeting smoothened. J Pathol (2011) 1.28
Phosphorylation and kinetics of mammalian cytochrome c oxidase. Mol Cell Proteomics (2008) 1.24
How reliable is pain as the fifth vital sign? J Am Board Fam Med (2009) 1.16
Regulation of mitochondrial uncoupling respiration during exercise in rat heart: role of reactive oxygen species (ROS) and uncoupling protein 2. Free Radic Biol Med (2008) 1.13
Humoral and cellular immune responses to Yersinia pestis infection in long-term recovered plague patients. Clin Vaccine Immunol (2011) 1.10
Expression of diabetes-associated genes by dendritic cells and CD4 T cells drives the loss of tolerance in nonobese diabetic mice. J Immunol (2009) 1.10
A Reg family protein is overexpressed in islets from a patient with new-onset type 1 diabetes and acts as T-cell autoantigen in NOD mice. Diabetes (2002) 1.10
Response of mitochondrial fusion and fission protein gene expression to exercise in rat skeletal muscle. Biochim Biophys Acta (2009) 1.10
TGF-beta signaling is required for the function of insulin-reactive T regulatory cells. J Clin Invest (2006) 1.09
Distribution of parvovirus B19 DNA in blood compartments and persistence of virus in blood donors. Transfusion (2011) 1.09
Toll-like receptors and diabetes. Ann N Y Acad Sci (2008) 1.09
Secreted frizzled-related protein disrupts PCP in eye lens fiber cells that have polarised primary cilia. Dev Biol (2009) 1.08
Glucose and collagen regulate human platelet activity through aldose reductase induction of thromboxane. J Clin Invest (2011) 1.07
Factors associated with clinician intention to address diverse aspects of pain in seriously ill outpatients. Pain Med (2010) 1.05
FoxM1 expression is significantly associated with cisplatin-based chemotherapy resistance and poor prognosis in advanced non-small cell lung cancer patients. Lung Cancer (2012) 1.04
Activation of insulin-reactive CD8 T-cells for development of autoimmune diabetes. Diabetes (2009) 1.04
Relative distribution of West Nile virus RNA in blood compartments: implications for blood donor nucleic acid amplification technology screening. Transfusion (2011) 1.02
Damage of oxidative stress on mitochondria during microspores development in Honglian CMS line of rice. Plant Cell Rep (2006) 1.01
The role of Toll-like receptors 3 and 9 in the development of autoimmune diabetes in NOD mice. Ann N Y Acad Sci (2008) 1.01
Clear cell tumor of the lung: a case report and literature review. World J Surg Oncol (2013) 1.01
Early identification of co-occurring pain, depression and anxiety. J Gen Intern Med (2009) 1.00
Cellular and humoral immune responses in the early stages of diabetic nephropathy in NOD mice. J Autoimmun (2009) 1.00
New extension of the Mitchell Theory for oxidative phosphorylation in mitochondria of living organisms. Biochim Biophys Acta (2009) 0.97
MR imaging of tumor angiogenesis using sterically stabilized Gd-DTPA liposomes targeted to CD105. Eur J Radiol (2008) 0.96
Modulation of permeability and adhesion molecule expression by human choroidal endothelial cells. Invest Ophthalmol Vis Sci (2002) 0.95
Expression of tryptophan 2,3-dioxygenase and production of kynurenine pathway metabolites in triple transgenic mice and human Alzheimer's disease brain. PLoS One (2013) 0.93
Impact of genetics and environment on nutritional and metabolite components of maize grain. J Agric Food Chem (2007) 0.93
TLR4 regulates cardiac lipid accumulation and diabetic heart disease in the nonobese diabetic mouse model of type 1 diabetes. Am J Physiol Heart Circ Physiol (2012) 0.92
Insulinoma-released exosomes or microparticles are immunostimulatory and can activate autoreactive T cells spontaneously developed in nonobese diabetic mice. J Immunol (2011) 0.92
Upregulation of uncoupling protein-3 in skeletal muscle during exercise: a potential antioxidant function. Free Radic Biol Med (2008) 0.92
Functional assessment of TSC1 missense variants identified in individuals with tuberous sclerosis complex. Hum Mutat (2012) 0.92
The TNF (-308A) polymorphism is associated with microchimerism in transfused trauma patients. Blood (2008) 0.92
ICOS mediates the development of insulin-dependent diabetes mellitus in nonobese diabetic mice. J Immunol (2008) 0.92
Immunogenicity, safety, and protective efficacy of an inactivated SARS-associated coronavirus vaccine in rhesus monkeys. Vaccine (2005) 0.91
Effect of Müller cell co-culture on in vitro permeability of bovine retinal vascular endothelium in normoxic and hypoxic conditions. Neurosci Lett (2005) 0.91
IL-10-conditioned dendritic cells prevent autoimmune diabetes in NOD and humanized HLA-DQ8/RIP-B7.1 mice. Clin Immunol (2011) 0.90
Overexpression of FOXM1 predicts poor prognosis and promotes cancer cell proliferation, migration and invasion in epithelial ovarian cancer. J Transl Med (2014) 0.90
The dual effects of B cell depletion on antigen-specific T cells in BDC2.5NOD mice. J Immunol (2012) 0.89
TLR9 deficiency promotes CD73 expression in T cells and diabetes protection in nonobese diabetic mice. J Immunol (2013) 0.87
Role of IRAK-M in alcohol induced liver injury. PLoS One (2013) 0.87
Converting antigen-specific diabetogenic CD4 and CD8 T cells to TGF-beta producing non-pathogenic regulatory cells following FoxP3 transduction. J Autoimmun (2007) 0.86
Combination treatment with anti-CD20 and oral anti-CD3 prevents and reverses autoimmune diabetes. Diabetes (2013) 0.86
The role of gut microbiota in the development of type 1, type 2 diabetes mellitus and obesity. Rev Endocr Metab Disord (2015) 0.86
Subcutaneous phaeohyphomycosis caused by Cladosporium sphaerospermum. Mycoses (2008) 0.85
A humanized mouse model of autoimmune insulitis. Diabetes (2014) 0.85
Microchimerism decades after transfusion among combat-injured US veterans from the Vietnam, Korean, and World War II conflicts. Transfusion (2008) 0.85
Associations between XPD Asp312Asn polymorphism and risk of head and neck cancer: a meta-analysis based on 7,122 subjects. PLoS One (2012) 0.84
Metabolically engineered soybean seed with enhanced threonine levels: biochemical characterization and seed-specific expression of lysine-insensitive variants of aspartate kinases from the enteric bacterium Xenorhabdus bovienii. Plant Biotechnol J (2011) 0.84
Inflammatory regulation by TLR3 in acute hepatitis. J Immunol (2009) 0.84
Delayed flood recession in central Yangtze floodplains can cause significant food shortages for wintering geese: results of inundation experiment. Environ Manage (2014) 0.84
Morphological characterization of hantavirus HV114 by electron microscopy. Intervirology (2007) 0.82
Using soybean trypsin inhibitor as an external loading control for Western blot analysis of tear proteins: application to corneal disease. Exp Eye Res (2012) 0.82
The study of HLA class II and autoimmune diabetes. Curr Mol Med (2003) 0.82
CD86 has sustained costimulatory effects on CD8 T cells. J Immunol (2007) 0.82
Metabolite analyses of grain from maize hybrids grown in the United States under drought and watered conditions during the 2002 field season. J Agric Food Chem (2007) 0.82
Modulatory role of DR4- to DQ8-restricted CD4 T-cell responses and type 1 diabetes susceptibility. Diabetes (2006) 0.82
MiR-451 suppresses cell proliferation and metastasis in A549 lung cancer cells. Mol Biotechnol (2015) 0.82
Immunotargeting of insulin reactive CD8 T cells to prevent diabetes. J Autoimmun (2010) 0.82
Tear levels of SFRP1 are significantly reduced in keratoconus patients. Mol Vis (2013) 0.81
IFN-alpha can both protect against and promote the development of type 1 diabetes. Ann N Y Acad Sci (2008) 0.81
Autoimmune diabetes in HLA-DR3/DQ8 transgenic mice expressing the co-stimulatory molecule B7-1 in the beta cells of islets of Langerhans. Int Immunol (2003) 0.81
The role of Gr1+ cells after anti-CD20 treatment in type 1 diabetes in nonobese diabetic mice. J Immunol (2011) 0.81
Toll-like receptor 3 is critical for coxsackievirus B4-induced type 1 diabetes in female NOD mice. Endocrinology (2014) 0.80
Anti-CD20 treatment prolongs syngeneic islet graft survival and delays the onset of recurrent autoimmune diabetes. Ann N Y Acad Sci (2008) 0.80
A potentially functional polymorphism in the regulatory region of let-7a-2 is associated with an increased risk for diabetic nephropathy. Gene (2013) 0.80
Epicutaneous immunization with DNP-BSA induces CD4+ CD25+ Treg cells that inhibit Tc1-mediated CS. Immunol Cell Biol (2012) 0.80
Basigin-2 is the predominant basigin isoform that promotes tumor cell migration and invasion and correlates with poor prognosis in epithelial ovarian cancer. J Transl Med (2013) 0.80
The A55T and K153R polymorphisms of MSTN gene are associated with the strength training-induced muscle hypertrophy among Han Chinese men. J Sports Sci (2014) 0.80
Progesterone modulates the proliferation and differentiation of human periodontal ligament cells. Calcif Tissue Int (2010) 0.80
Age-dependent loss of tolerance to an immunodominant epitope of glutamic acid decarboxylase in diabetic-prone RIP-B7/DR4 mice. Clin Immunol (2006) 0.80
Hypoglycemic polysaccharides from the tuberous root of Liriope spicata. J Nat Prod (2009) 0.80
Prediction of the severity of acute pancreatitis on admission by urinary trypsinogen activation peptide: a meta-analysis. World J Gastroenterol (2013) 0.79
Expression of SFRP Family Proteins in Human Keratoconus Corneas. PLoS One (2013) 0.79
Nursing staff, patient, and environmental factors associated with accurate pain assessment. J Pain Symptom Manage (2010) 0.79
Novel lipophilic probe for detecting near-membrane reactive oxygen species responses and its application for studies of pancreatic acinar cells: effects of pyocyanin and L-ornithine. Antioxid Redox Signal (2014) 0.79
Routes of inoculation and the immune response to a resolving genital flavivirus infection in a novel murine model. Immunol Cell Biol (2004) 0.79
Importance of TLR2 in the direct response of T lymphocytes to Schistosoma mansoni antigens. Eur J Immunol (2010) 0.79
The influence of the major histocompatibility complex on development of autoimmune diabetes in RIP-B7.1 mice. Diabetes (2005) 0.79
Hepatitis mouse models: from acute-to-chronic autoimmune hepatitis. Int J Exp Pathol (2014) 0.79
To B or not to B--pathogenic and regulatory B cells in autoimmune diabetes. Curr Opin Immunol (2010) 0.79
The study on causes of death in fulminant pancreatitis at early stage and late stage. Sichuan Da Xue Xue Bao Yi Xue Ban (2011) 0.79
Sfrp1 and Sfrp2 are not involved in Wnt/β-catenin signal silencing during lens induction but are required for maintenance of Wnt/β-catenin signaling in lens epithelial cells. Dev Biol (2013) 0.78
Application of thresholds of potential concern and limits of acceptable change in the condition assessment of a significant wetland. Environ Monit Assess (2013) 0.78
Clinical investigation of posttransfusion Kidd blood group typing using a rapid normalized quantitative polymerase chain reaction. Transfusion (2004) 0.78
Developing a novel model system to target insulin-reactive CD8 T cells. Ann N Y Acad Sci (2008) 0.78
Association between HMOX-1 genotype and cardiac function during exercise. Appl Physiol Nutr Metab (2008) 0.78
Pediatric esophageal leiomyosarcoma: a case report. J Pediatr Surg (2011) 0.78
CD8+ T-cells and their interaction with other cells in damage to islet beta-cells. Biochem Soc Trans (2008) 0.78
Retracted ATF3 and extracellular matrix-related genes associated with the process of chronic obstructive pulmonary. Lung (2014) 0.77